drugset / Trial / NCT07016802
A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
RandomizedSequentialQuadruple-blindTreatment
Summary
To check how safe and well-tolerated a single subcutaneous injection of GenSc134 is in healthy male volunteers， a multiple-doses subcutaneous injection of GenSc134 is in healthy volunteers，a single subcutaneous injection of GenSc134 is in AGHD patients.
Timeline
- Start
- 2025-06-09
- Primary completion
- 2026-11-25
- Completion
- 2026-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GenSci134 | Unknown | — | — |
| Comparator | Somatropin | Protein / enzyme biologic | 0.2 mg | — |